ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Twist Bioscience Corp. ?
1
With a growth in Net Sales of 16.89%, the company declared Very Positive results in Dec 25
- OPERATING CASH FLOW(Y) Highest at USD -51.01 MM
- NET PROFIT(HY) Higher at USD -57.65 MM
- ROCE(HY) Highest at -16.79%
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 23.66%, its profits have risen by 50.4%
3
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Market Beating performance in long term as well as near term
- Along with generating 23.66% returns in the last 1 year, the stock has outperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Twist Bioscience Corp. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Twist Bioscience Corp. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Twist Bioscience Corp.
19.75%
-0.14
68.24%
S&P 500
21.6%
1.08
19.33%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
31.10%
EBIT Growth (5y)
-3.18%
EBIT to Interest (avg)
-182.69
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.55
Sales to Capital Employed (avg)
0.63
Tax Ratio
0.19%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.13
EV to EBIT
-12.23
EV to EBITDA
-14.86
EV to Capital Employed
7.17
EV to Sales
4.81
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-58.61%
ROE (Latest)
-17.81%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend13What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -51.01 MM
NET PROFIT(HY)
Higher at USD -57.65 MM
ROCE(HY)
Highest at -16.79%
NET SALES(Q)
Highest at USD 103.7 MM
RAW MATERIAL COST(Y)
Fallen by -7.95% (YoY
-2What is not working for the Company
CASH AND EQV(HY)
Lowest at USD 430.38 MM
DEBT-EQUITY RATIO
(HY)
Highest at -21.9 %
Here's what is working for Twist Bioscience Corp.
Operating Cash Flow
Highest at USD -51.01 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Net Sales
Highest at USD 103.7 MM and Grown
In each period in the last five periodsMOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Net Profit
Higher at USD -57.65 MM
than preceding 12 month period ended Dec 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Raw Material Cost
Fallen by -7.95% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Twist Bioscience Corp.
Cash and Eqv
Lowest at USD 430.38 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at -21.9 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
